Prevention of Future Deaths reports · 2016

Curt Falk

Regulation 28 report to prevent future deaths, reference 2016-0083, written 2 Mar 2016. A coroner writes one of these when an inquest reveals a risk that could cause further deaths unless something changes.

Date of report2 Mar 2016
Reference2016-0083
DeceasedCurt Falk
CoronerR Brittain
Coroner areaInner North London
CategoryHospital Death (Clinical Procedures and medical management) related deaths
Sourcejudiciary.uk record · original PDF
Responses published1

The report

Text extracted from the PDF text layer. Reproduced verbatim, including the scan's own layout.

REGULATION 28:  REPORT TO PREVENT FUTURE DEATHS 

REGULATION 28 REPORT TO PREVENT FUTURE DEATHS 

THIS REPORT IS BEING SENT TO: 

(1)

Vaccination and Immunisation, ℅
, London.  
79 Whitehall
​

Joint Committee on
,
Chair HPV Subcommittee
​
​
Department of Health, Richmond House,
​

1 

CORONER 

I am R Brittain, Assistant Coroner for Inner North London 

2 

CORONER’S LEGAL POWERS 

I make this report under paragraph 7, Schedule 5, of the Coroners and Justice Act 2009
and regulations 28 and 29 of the Coroners (Investigations) Regulations 2013. 

3 

INVESTIGATION and INQUEST 

Curt Falk died on 6 July 2015, aged 65 years old, from acute myeloid leukaemia. An
inquest into his death was part­heard on 22 January 2016 and concluded on 26 February
2016, at which I recorded a narrative conclusion (see attached).  

4 

CIRCUMSTANCES OF THE DEATH 

Mr Falk was diagnosed in early 2015 with squamous cell carcimona (SCC) of the tongue
(resulting from Human Papilloma Virus strain 16) and a blood disorder which was
categorised variably as ‘high risk myelodysplasia’ (MDS) and ‘acute myeloid leukaemia’
(AML). 

He underwent curative radiotherapy for the SCC; however, this treatment plan meant that
the MDS/AML was not treatable prior to his death.  

5 

CORONER’S CONCERNS 

During the course of the inquest the evidence revealed matters giving rise to concern. In
my opinion there is a risk that future deaths will occur unless action is taken. In the
circumstances it is my statutory duty to report to you. 

The 

MATTERS OF CONCERN
​

 are as follows.  –  
​

(1) The SCC from which Mr Falk suffered resulted from a viral infection, which is now
potentially preventable through vaccination. This issue did not form part of the evidence
heard at the inquest because it was not directly relevant to Mr Falk’s death. However, I am
concerned that current vaccination policy does not include the vaccination of males
against this virus. As such, there is a risk that future deaths could occur in men from the
consequences of this infection.  

1 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  6  ACTION COULD BE TAKEN 

In my opinion action could be taken to prevent future deaths and I believe that the
addressee, has the power potentially to take such action. I am aware of the complexities
if
involved in the institution of mass vaccination campaigns and would be grateful
information could be provided regarding the current and potential
future scope for
vaccinating the population as a whole against this virus.  

7 

YOUR RESPONSE 

You are under a duty to respond to this report within 56 days of the date of this report,
namely by 27 April 2016. I, the coroner, may extend the period. 

Your response must contain details of action taken or proposed to be taken, setting out the
timetable for action. Otherwise you must explain why no action is proposed. 

8 

COPIES and PUBLICATION 

I have sent a copy of my report to the Chief Coroner; Mr Falk’s family;
Consultant Haematologist;
University Hospital. 

Consultant Oncologist and Harley Street at

I am also under a duty to send the Chief Coroner a copy of your response.  

The Chief Coroner may publish either or both in a complete or redacted or summary form.
He may send a copy of this report to any person who he believes may find it useful or of
interest. You may make representations to me, the coroner, at the time of your response,
about the release or the publication of your response by the Chief Coroner. 

9 

2 March 2016 
Assistant Coroner R Brittain 

2

Responses

1 response published against this report on judiciary.uk. A response is a body's written reply to the coroner's concerns; publication is at the discretion of the Chief Coroner's office, so an absent response does not mean nobody replied.

Response from Jcvi (PDF)
Richard Brittain 

Assistant Coroner, 

PA to Senior Coroner 

St Pancras Coroners Court, 

Camley Street, 

London, N1C 4PP. 

19 April 2016 

Re: Curt Falk (died: 06.07.2015) Regulation 28:  

Report to Prevent Future Deaths   

Dear Mr Britten, 

The Joint Committee on Vaccination and Immunisation (JCVI) is an independent 
Departmental Expert Committee and a statutory body, constituted for the purpose of 
advising the Secretary of State on the provision of vaccination and immunisation 
services.  

JCVI’s advice and recommendations are based on consideration of scientific 
evidence from different sources including clinical trials epidemiological reports and 
impact and cost-effectiveness studies. In order to form a recommendation for a new 
national programme or changes to an existing national programme the Committee 
must ensure that this represents the best use of NHS resources by demonstrating 
cost-effectiveness. 

The aim of the UK’s current HPV vaccination programme is to prevent HPV related 
cervical cancers. The programme was introduced in 2008 following the advice of the 
JCVI which carried out a detailed review of evidence surrounding HPV vaccination 
including the cost effectiveness of routine and catch-up programmes. At that time 
JCVI did not recommend vaccination of boys because the evidence indicated 
vaccinating boys was unlikely to be cost-effective, as vaccine efficacy was high, and 
high coverage in girls would provide herd protection for boys, meaning that a 
programme which included boys would provide little additional benefit. The coverage 
of the HPV programme is high. In the last three years, coverage of the routine 
programme for the full three-dose course has been consistently above 86%. 

JCVI keeps the eligibility criteria of all vaccination programmes under review. In 
October 2013 JCVI recommended a HPV sub-committee be formed to consider a 
number of issues including vaccinating men who have sex with men (MSM) and the 
potential extension of the programme to include adolescent boys, because of new 
and emerging evidence on the association of HPV vaccine types with non-cervical 
cancers. 

JCVI subsequently requested that modelling be undertaken by Public Health 
England (PHE) to re-examine the impact and cost-effectiveness of extending the 

  
 
 
 
 
 
 
 HPV vaccination programme to adolescent boys. It is anticipated that PHE will 
submit the work on the cost-effectiveness of extending the HPV vaccination 
programme to adolescent boys to JCVI by early 2017. 

Modeling work on vaccinating MSM was already underway as this was considered a 
priority because this is a group that receives very little indirect benefit from the girls 
programme. In November 2015 JCVI issued a statement advising that a targeted 
HPV vaccination programme for MSM aged up to 45 who attend GUM and HIV 
clinics should be undertaken subject to procurement of the vaccine and delivery of 
the programme at a cost-effective price.  

For more information I recommend you access the JCVI webpage which has the 
latest minutes and statements from JCVI meetings. I have attached the JCVI code of 
practice which gives details about the Committee and provided links below to the 
relevant JCVI documents concerning the subject of HPV vaccination. 

JCVI web page: https://www.gov.uk/government/groups/joint-committee-on-
vaccination-and-immunisation#terms-of-reference 

JCVI 2008 statement on HPV vaccines to protect against cervical cancer: 
http://webarchive.nationalarchives.gov.uk/20120907090205/http://www.dh.gov.uk/pr
od_consum_dh/groups/dh_digitalassets/@dh/@ab/documents/digitalasset/dh_0947
39.pdf 

Minutes of the JCVI HPV Subcommittee: 
https://app.box.com/s/600veu6zr6s3gjvx8mkt 

JCVI statement on HPV vaccination of men who have sex with men: 
https://www.gov.uk/government/publications/jcvi-statement-on-hpv-vaccination-of-
men-who-have-sex-with-men  

Kind regards 

Scientific Secretariat to the Joint Committee on Vaccination and Immunisation 

Public Health England,  

Wellington House,  

133-155 Waterloo Road 

London SE1 8UG 

Email: jcvi@phe.gov.uk 

 Chair of JCVI HPV Subcommittee

Related reports

Other reports by R Brittain

See all →

More reports categorised “Hospital Death (Clinical Procedures and medical management) related deaths”

See all →

Track Hospital Death (Clinical Procedures and medical management) related deaths

See every Prevention of Future Deaths report matching Hospital Death (Clinical Procedures and medical management) related deaths, and how often a new one appears.

What would an alert for this have sent me? Search the full text

Free to try — the preview shows the real matches and how many arrived in the last 12 months. Your first email alert is free.

These reports are published by the Chief Coroner's office at judiciary.uk and are © Crown copyright. The text here is reproduced from the published PDF so it can be searched. If something on this page is wrong, or you are a person named in it and want it reviewed, email drcjar@gmail.com and we will act promptly.